The highly mutated SARS-CoV-2 Omicron (B.1.1.529) variant has been shown to evade a
substantial fraction of neutralizing antibody responses elicited by current vaccines that encode …

The rapid spread of the SARS-CoV-2 Omicron (B.1.1.529) variant, including in highly
vaccinated populations, has raised important questions about the efficacy of current vaccines. In …

Importance Pregnant women are at increased risk of morbidity and mortality from COVID-19
but have been excluded from the phase 3 COVID-19 vaccine trials. Data on vaccine safety …

Kinetics of Immune Response to Covid-19 Vaccines B-cell and T-cell responses were
measured to assess the stability and duration of vaccine-induced immunity. Responses to …

Microbial communities have numerous potential applications in biotechnology, agriculture,
and medicine. Nevertheless, the limited accuracy with which we can predict interspecies …

There is much controversy regarding enhanced recovery for recipients of liver transplants
from deceased and living donors. The objectives of this Review were to summarise current …

The CVnCoV (CureVac) mRNA vaccine for severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) was recently evaluated in a phase 2b/3 efficacy trial in humans 1 . CV2CoV …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that result in
increased transmissibility and partial evasion of neutralizing antibodies have recently emerged. …

Breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants have been reported frequently in vaccinated individuals with waning immunity. In …

Ad26.COV2.S has demonstrated durability and clinical efficacy against symptomatic COVID-19
in humans. In this study, we report the correlates of durability of humoral and cellular …